# HTE Investment Group, LLC dba MD Dermis – FDA Inspection, Feb 2, 2018

Source: https://www.keypedia.com/records/fda_inspections/hte-investment-group-llc-dba-md-dermis/6741b0bd-83b9-4ffe-af90-50b8220fd5bc
Source feed: FDA_Inspections

> FDA inspection 1039505 of HTE Investment Group, LLC dba MD Dermis, February 02, 2018. Classification: Voluntary Action Indicated (VAI). 6 citations under 21 CFR parts 803 and 820. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1039505
- Company Name: HTE Investment Group, LLC dba MD Dermis
- Inspection Date: 2018-02-02
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Radiation Control and Health Safety Act
- Product Type: Devices
- Center: Medical Devices & Rad Health
- Office Name: Center for Devices and Radiological Health
- Citation Count: 6

## Related Documents

- FDA Inspection 1106126 - 2019-07-18

## Related Officers

- [Dianiris C. Ayala](https://www.keypedia.com/people/dianiris-c-ayala/ba6c5538-201b-4c9a-8f23-e160db6868e6)

Company: https://www.keypedia.com/companies/hte-investment-group-llc-dba-md-dermis/adca73b9-d989-4ac2-9ebc-7e28c82a2e60

Office: https://www.keypedia.com/offices/center-for-devices-and-radiological-health/9d89aff6-e435-4764-87be-f58c01aca7f7